European Archives - Page 525 of 1198 - European Medical Journal

Artificially intelligent drug discovery

AI is being implemented into drug development to free up time, money and manpower, but how can humans and computers work together?

Photoprotection and the Science Behind Skin Healing

Sun exposure can lead to tanning, but also to skin damage due to the actions of ultraviolet A and B, visible light, and infrared radiation. One result of sun exposure is field cancerisation (FC), the precursor to actinic keratosis (AK), which in turn is a risk factor for, most notably, squamous cell carcinoma.

EMJ Dermatology 10.1 2022

The latest issue of EMJ Dermatology is out now and features a review of the European Academy of Dermatology and Venerology (EADV) Congress 2022.

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2022

THIS YEAR, the European Academy of Dermatology and Venereology (EADV) adopted a pioneering hybrid format for its congress, allowing delegates to attend onsite in Milan, Italy, as well as online. Clinicians and academics came together with one common goal: to build an international community that develops, shares, and adopts best practices within the fields of dermatology and venereology.

Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer's Operating Systems

This symposium session presented at the ESMO 2022 included presentations exploring different and new aspects of treating patients.

Dermatoscopic Rainbow Pattern in Extragenital Lichen Sclerosus et Atrophicus

Lichen sclerosus et atrophicus (LSEA) is an inflammatory skin disease that most frequently affects pre-pubertal and post-menopausal females. It commonly affects anogenital skin; however, extragenital lesions are not uncommon and occur in isolation or concomitantly with genital lesions.

Designing the Future of Dermatology and Venereology

The European Academy of Dermatology and Venereology’s (EADV) 31st Congress took place between 7th and 10th September 2022. This hybrid congress offered both a long-awaited onsite experience and the opportunity to attend virtually from across the globe.

Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study

Chronic spontaneous urticaria (CSU) is characterised by the spontaneous occurrence of wheals (hives) and/or angioedema for ≥6 weeks.1 CSU can persist for several years and is associated with severe pruritus. Skin mast cell activation in CSU occurs via Type I autoallergy driven by IgE to autoallergens, and a Type IIb autoimmune response due to mast cell-targeted autoantibodies against IgE or high-affinity IgE receptor.

EADV 2022 Abstract Highlights

The following highlights spotlight abstracts presented at the European Academy of Dermatology and Venereology (EADV) Congress 2022, specifically focusing on the latest developments in nail disorders and urticaria.

Updates on Best Practices for Onychomycosis: Hitting the Nail on the Head

DURING the 31st Annual European Academy of Dermatology and Venereology (EADV) Congress, 7th–10th September 2022, held both in-person in Milan, Italy, and virtually, experts delivered a session on the topic of nail disorders.